80 related articles for article (PubMed ID: 7603351)
1. Comparative immunoblot analysis with ten different, partially overlapping recombinant fusion proteins derived from five different cytomegalovirus proteins.
Van Zanten J; Lazzarotto T; Campisi B; Vornhagen R; Jahn G; Landini MP; The TH
New Microbiol; 1995 Apr; 18(2):223-8. PubMed ID: 7603351
[TBL] [Abstract][Full Text] [Related]
2. IgM antibody detection of ppUL80A and ppUL32 by immunoblotting: an early parameter for recurrent cytomegalovirus infection in renal transplant recipients.
Kraat YJ; Stals FS; Christiaans MH; Lazzarotto T; Landini MP; Bruggeman CA
J Med Virol; 1996 Mar; 48(3):289-94. PubMed ID: 8801292
[TBL] [Abstract][Full Text] [Related]
3. Humoral immune response against human cytomegalovirus (HCMV)-specific proteins after HCMV infection in lung transplantation as detected with recombinant and naturally occurring proteins.
van Zanten J; Harmsen MC; van der Giessen M; van der Bij W; Prop J; de Leij L; The TH
Clin Diagn Lab Immunol; 1995 Mar; 2(2):214-8. PubMed ID: 7535179
[TBL] [Abstract][Full Text] [Related]
4. Construction of a polyepitope fusion antigen of human cytomegalovirus ppUL32 and detection of specific antibodies by ELISA.
Ripalti A; Boccuni MC; Campanini F; Bergamini G; Lazzarotto T; Battista MC; Dalla Casa B; Landini MP
New Microbiol; 1995 Jan; 18(1):1-12. PubMed ID: 7539096
[TBL] [Abstract][Full Text] [Related]
5. Comparison of immunological reactivity to two major antigens of homologous and AD169 human cytomegalovirus strains during primary infection in renal transplant patients.
Rossier E; Miller H; Dal Monte P; Boccuni C; Landini MP
New Microbiol; 1993 Jan; 16(1):1-9. PubMed ID: 8385731
[TBL] [Abstract][Full Text] [Related]
6. IgM-specific serodiagnosis of acute human cytomegalovirus infection using recombinant autologous fusion proteins.
Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Enders G; Jahn G; Plachter B
J Virol Methods; 1996 Jun; 60(1):73-80. PubMed ID: 8795008
[TBL] [Abstract][Full Text] [Related]
7. A novel Western blot test containing both viral and recombinant proteins for anticytomegalovirus immunoglobulin M detection.
Lazzarotto T; Maine GT; Dal Monte P; Ripalti A; Landini MP
J Clin Microbiol; 1997 Feb; 35(2):393-7. PubMed ID: 9003603
[TBL] [Abstract][Full Text] [Related]
8. Recombinant mono- and polyantigens to detect cytomegalovirus-specific immunoglobulin M in human sera by enzyme immunoassay.
Landini MP; Lazzarotto T; Maine GT; Ripalti A; Flanders R
J Clin Microbiol; 1995 Oct; 33(10):2535-42. PubMed ID: 8567879
[TBL] [Abstract][Full Text] [Related]
9. Immunoassay with cytomegalovirus early antigens from gene products p52 and CM2 (UL44 and UL57) detects active infection in patients with chronic fatigue syndrome.
Beqaj SH; Lerner AM; Fitzgerald JT
J Clin Pathol; 2008 May; 61(5):623-6. PubMed ID: 18037660
[TBL] [Abstract][Full Text] [Related]
10. Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection.
Landini MP; Lazzarotto T; Ripalti A; Guan MX; La Placa M
J Clin Microbiol; 1989 Oct; 27(10):2324-7. PubMed ID: 2555392
[TBL] [Abstract][Full Text] [Related]
11. Human antibody response to human cytomegalovirus-specific DNA-binding proteins.
Gergely L; Czeglédy J; Váczi L
Acta Virol; 1988 Jan; 32(1):1-5. PubMed ID: 2897767
[TBL] [Abstract][Full Text] [Related]
12. Antibody response to cytomegalovirus (CMV) polypeptides in liver transplant recipients with CMV hepatitis.
Lazzarotto T; Paya CV; Smith TF; Wiesner RH; Krom R; Landini MP
Microbiologica; 1992 Jan; 15(1):15-22. PubMed ID: 1313529
[TBL] [Abstract][Full Text] [Related]
13. Expression of tegument protein pp65 of human cytomegalovirus (CMV) and its application to the analysis of viral-specific cellular immunity in CMV-infected individuals.
Tanaka N; Kimura H; Hoshino Y; Nishikawa K; Kojima S; Nishiyama Y; Morishima T
Arch Virol; 2002 Dec; 147(12):2405-17. PubMed ID: 12491106
[TBL] [Abstract][Full Text] [Related]
14. Combination of native and recombinant cytomegalovirus antigens in a new ELISA for detection of CMV-specific antibodies.
Busse C; Strubel A; Schnitzler P
J Clin Virol; 2008 Oct; 43(2):137-41. PubMed ID: 18621576
[TBL] [Abstract][Full Text] [Related]
15. Is combined pretransplantation seropositivity of kidney transplant recipients for cytomegalovirus antigens (pp150 and pp28) a predictor for protection against infection?
Essa S; Pacsa A; Said T; Nampoory MR; Raghupathy R; Johny KV; Al-Nakib W; Al-Mosawy M
Med Princ Pract; 2008; 17(1):66-70. PubMed ID: 18059104
[TBL] [Abstract][Full Text] [Related]
16. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
[TBL] [Abstract][Full Text] [Related]
17. Molecular dissection of the human B cell response against cytomegalovirus infection by lambda display.
Beghetto E; Paolis FD; Spadoni A; Del Porto P; Buffolano W; Gargano N
J Virol Methods; 2008 Jul; 151(1):7-14. PubMed ID: 18499273
[TBL] [Abstract][Full Text] [Related]
18. Proliferative T cell responses to four human cytomegalovirus-specific proteins in healthy subjects and solid organ transplant recipients.
van Zanten J; Harmsen MC; van der Meer P; van der Bij W; van Son WJ; van der Giessen M; Prop J; de Leij L; The TH
J Infect Dis; 1995 Sep; 172(3):879-82. PubMed ID: 7658088
[TBL] [Abstract][Full Text] [Related]
19. The DNA-binding protein pUL57 of human cytomegalovirus is a major target antigen for the immunoglobulin M antibody response during acute infection.
Vornhagen R; Hinderer W; Sonneborn HH; Bein G; Matter L; The TH; Jahn G; Plachter B
J Clin Microbiol; 1995 Jul; 33(7):1927-30. PubMed ID: 7665674
[TBL] [Abstract][Full Text] [Related]
20. Construction of polyepitope fusion antigens of human cytomegalovirus ppUL32: reactivity with human antibodies.
Ripalti A; Ruan Q; Boccuni MC; Campanini F; Bergamini G; Landini MP
J Clin Microbiol; 1994 Feb; 32(2):358-63. PubMed ID: 7512094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
